Pulmonary nodules in Denmark: occurrence, resource use, and risk of lung cancer and death
DOI:
https://doi.org/10.2340/1651-226X.2025.44711Keywords:
Pulmonary nodules, epidemiology, lung cancer, chest CT scans, mortalityAbstract
Background and purpose: Little is known about how pulmonary nodules are managed in routine clinical care. We examined their occurrence, the use of computed tomography (CT) scans, referrals to cancer pathways, and the risk of lung cancer and death post-diagnosis.
Patients/material and methods: We conducted a population-based cohort study using Danish health registry data. We identified all adults with a first-time pulmonary nodule diagnosis from 2018 to 2022. We examined the incidence of pulmonary nodules using age- and sex-standardized incidence rates (SIRs). We used the Aalen-Johansen estimator to calculate the probability of receiving a chest CT scan, a cancer patient pathway referral, the risk of lung cancer, and mortality within 12 months after a nodule diagnosis.
Results: We identified 43,209 patients with a pulmonary nodule diagnosis. The age- and sex-SIR of pulmonary nodules was 197 per 100,000 person-years in 2018, declining to 186 per 100,000 person-years in 2022. Within 12 months after a nodule diagnosis, 68.3% of the cohort underwent at least one chest CT scan, with 51.0% receiving a low-dose chest CT scan and 7.2% receiving a referral to a lung cancer patient pathway. The 12-month lung cancer risk was 3.6% (95% CI, 3.4 to 3.8%), with the highest risk for stage I lung cancer, and the mortality was 7.0% (95% CI, 6.8 to 7.3%).
Interpretation: The incidence of pulmonary nodules remained relatively stable from 2018 to 2022. More than 30% of patients with nodules lacked a chest CT scan within 12 months after a pulmonary nodule diagnosis.
Downloads
References
[1] GBD 2019 Respiratory Tract Cancers Collaborators. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir Med. 2021;9(9):1030–49.
[2] Rasmussen TR, Jakobsen E, Rasmussen C, Madsen M. Dansk Lunge Cancer Register, Årsrapport 2022. 2023. The Danish Lung Cancer group. https://www.lungecancer.dk/rapporter/aarsrapporter/
[3] Callister MEJ, Baldwin DR, Akram AR, Barnard S, Cane P, Draffan J, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE. Thorax. 2015;70(Suppl 2):ii1–ii54.
https://doi.org/10.1136/thoraxjnl-2015-207168 DOI: https://doi.org/10.1136/thoraxjnl-2015-207168
[4] Borg M, Rasmussen TR, Hilberg O. Introduction of the Danish Lung Nodule Registry: a part of the Danish Lung Cancer Registry. Cancer Epidemiol. 2024;89:102543.
https://doi.org/10.1016/j.canep.2024.102543 DOI: https://doi.org/10.1016/j.canep.2024.102543
[5] Mazzone PJ, Lam L. Evaluating the patient with a pulmonary nodule: a review. JAMA. 2022;327(3):264–73.
https://doi.org/10.1001/jama.2021.24287 DOI: https://doi.org/10.1001/jama.2021.24287
[6] Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307(22):2418–29.
https://doi.org/10.1001/jama.2012.5521 DOI: https://doi.org/10.1001/jama.2012.5521
[7] Schmid-Bindert G, Vogel-Claussen J, Gütz S, Fink J, Hoffmann H, Eichhorn ME, et al. Incidental pulmonary nodules – what do we know in 2022. Respiration. 2022;101(11):1024–34. https://doi.org/10.1159/000526818 DOI: https://doi.org/10.1159/000526818
[8] Borg M, Hilberg O, Andersen MB, Weinreich UM, Rasmussen TR. Increased use of computed tomography in Denmark: stage shift toward early stage lung cancer through incidental findings. Acta Oncol. 2022;61(10):1256–62.
https://doi.org/10.1080/0284186X.2022.2135134 DOI: https://doi.org/10.1080/0284186X.2022.2135134
[9] Gould MK, Tang T, Liu I-LA, Lee J, Zheng C, Danforth KN, et al. Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med. 2015;192(10):1208–14.
https://doi.org/10.1164/rccm.201505-0990OC DOI: https://doi.org/10.1164/rccm.201505-0990OC
[10] Blagev DP, Lloyd JF, Conner K, Dickerson J, Adams D, Stevens SM, et al. Follow-up of incidental pulmonary nodules and the radiology report. J Am Coll Radiol. 2014;11(4):378–83.
https://doi.org/10.1016/j.jacr.2013.08.003 DOI: https://doi.org/10.1016/j.jacr.2013.08.003
[11] Iaccarino JM, Steiling K, Slatore CG, Drainoni ML, Wiener RS. Patient characteristics associated with adherence to pulmonary nodule guidelines. Respir Med. 2020;171:106075.
https://doi.org/10.1016/j.rmed.2020.106075 DOI: https://doi.org/10.1016/j.rmed.2020.106075
[12] Verdial FC, Madtes DK, Cheng GS, Pipavath S, Kim R, Hubbard JJ, et al. Multidisciplinary team-based management of incidentally detected lung nodules. Chest. 2020;157(4):985–93.
https://doi.org/10.1016/j.chest.2019.11.032 DOI: https://doi.org/10.1016/j.chest.2019.11.032
[13] Wiener RS, Gould MK, Slatore CG, Fincke BG, Schwartz LM, Woloshin S. Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care. JAMA Intern Med. 2014;174(6):871–80.
https://doi.org/10.1001/jamainternmed.2014.561 DOI: https://doi.org/10.1001/jamainternmed.2014.561
[14] Pyenson BS, Bazell CM, Bellanich MJ, Caplen MA, Zulueta JJ. No apparent workup for most new indeterminate pulmonary nodules in US Commercially-insured patients. J Health Econom Outcomes Res. 2019;6(3):118–29.
https://doi.org/10.36469/9674 DOI: https://doi.org/10.36469/9674
[15] Schmidt M, Schmidt SAJ, Adelborg K, Sundboll J, Laugesen K, Ehrenstein V, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–91.
https://doi.org/10.2147/CLEP.S179083 DOI: https://doi.org/10.2147/CLEP.S179083
[16] Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–9.
https://doi.org/10.1007/s10654-014-9930-3 DOI: https://doi.org/10.1007/s10654-014-9930-3
[17] Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–90.
https://doi.org/10.2147/CLEP.S91125 DOI: https://doi.org/10.2147/CLEP.S91125
[18] Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7 Suppl):42–5.
https://doi.org/10.1177/1403494810393562 DOI: https://doi.org/10.1177/1403494810393562
[19] MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 2017;284(1):228–43.
https://doi.org/10.1148/radiol.2017161659 DOI: https://doi.org/10.1148/radiol.2017161659
[20] Jensen H, Tørring ML, Olesen F, Overgaard J, Fenger-Grøn M, Vedsted P. Diagnostic intervals before and after implementation of cancer patient pathways – a GP survey and registry based comparison of three cohorts of cancer patients. BMC Cancer. 2015;15(1):308.
https://doi.org/10.1186/s12885-015-1317-7 DOI: https://doi.org/10.1186/s12885-015-1317-7
[21] Gouliaev A, Ali F, Jakobsen E, Dalton SO, Hilberg O, Rasmussen TR, et al. The Danish lung cancer registry: a nationwide validation study. Lung Cancer. 2024;190:107527.
https://doi.org/10.1016/j.lungcan.2024.107527 DOI: https://doi.org/10.1016/j.lungcan.2024.107527
[22] Dong H, Robison LL, Leisenring WM, Martin LJ, Armstrong GT, Yasui Y. Estimating the burden of recurrent events in the presence of competing risks: the method of mean cumulative count. Am J Epidemiol. 2015;181(7):532–40.
https://doi.org/10.1093/aje/kwu289 DOI: https://doi.org/10.1093/aje/kwu289
[23] Arshad A, Harders S, Andersen M. Praktisk håndtering af pulmonale noduli 2021 [updated October 1 2021]. [Date of visit: 20/8/2025] Available from: https://lungemedicin.dk/wp-content/uploads/2022/03/Praktisk-haandtering-af-pulmonale-noduli.pdf
[24] Pinsky PF, Gierada DS, Nath PH, Munden R. Lung cancer risk associated with new solid nodules in the National Lung Screening Trial. Am J Roentgenol. 2017;209(5):1009–14.
https://doi.org/10.2214/AJR.17.18252 DOI: https://doi.org/10.2214/AJR.17.18252
[25] Koning HJd, Aalst CMvd, Jong PAd, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–13.
https://doi.org/10.1056/NEJMoa1911793 DOI: https://doi.org/10.1056/NEJMoa1911793
[26] Hendrix W, Rutten M, Hendrix N, Van Ginneken B, Schaefer-Prokop C, Scholten ET, et al. Trends in the incidence of pulmonary nodules in chest computed tomography: 10-year results from two Dutch hospitals. Eur Radiol. 2023;33(11):8279–88.
https://doi.org/10.1007/s00330-023-09826-3 DOI: https://doi.org/10.1007/s00330-023-09826-3
[27] Pinsky P, Miller E, Faris N, Osarogiagbon R. Pulmonary nodules, lung cancer screening, and lung cancer in the medicare population. Chest. 2023;163(5):1304–13.
https://doi.org/10.1016/j.chest.2022.12.006 DOI: https://doi.org/10.1016/j.chest.2022.12.006
[28] Borg M, Kristensen K, Alstrup G, Mamaeva T, Arshad A, Laursen CB, et al. Consequences of losing incidental pulmonary nodules to follow-up: unmonitored nodules progressing to stage IV lung cancer. Respiration. 2024;103(2):53–9.
https://doi.org/10.1159/000535595 DOI: https://doi.org/10.1159/000535595
[29] Farjah F, Monsell SE, Greenlee RT, Gould MK, Smith-Bindman R, Banegas MP, et al. Patient and nodule characteristics associated with a lung cancer diagnosis among individuals with incidentally detected lung nodules. Chest. 2023;163(3):719–30.
https://doi.org/10.1016/j.chest.2022.09.030 DOI: https://doi.org/10.1016/j.chest.2022.09.030
[30] Skjøth F, Nielsen H, Bodilsen J. Validity of algorithm for classification of in- and outpatient hospital contacts in the Danish National Patient Registry. Clin Epidemiol. 2022;14:1561–70.
https://doi.org/10.2147/CLEP.S380023 DOI: https://doi.org/10.2147/CLEP.S380023
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Cecilia Hvitfeldt Fuglsang, Ina Trolle Andersen, Frederik Pagh Bredahl Kristensen, Henriette Engberg, Morten Borg, Ole Hilberg, Torben Riis Rasmussen
This work is licensed under a Creative Commons Attribution 4.0 International License.
